These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1037 related articles for article (PubMed ID: 24507208)
1. [Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?]. Schoeffler A; Levy E; Weinborn M; Cuny JF; Schmutz JL; Barbaud A; Cribier B; Bursztejn AC Ann Dermatol Venereol; 2014 Feb; 141(2):134-40. PubMed ID: 24507208 [TBL] [Abstract][Full Text] [Related]
2. An unusual case of spontaneous remission of Hodgkin's disease after a single cycle of COPP-ABV chemotherapy followed by infectious complications. Bang SM; Cheong JW; Yang WI; Hahn JS Yonsei Med J; 2005 Jun; 46(3):425-30. PubMed ID: 15988816 [TBL] [Abstract][Full Text] [Related]
3. Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report. Nicolatou-Galitis O; Papadaki T; Moschovi M; Kamma JJ; van Vliet-Constantinidou C; Tsoumakas C; Kattamis A; Tzortzatou-Stathopoulou F J Periodontol; 2001 Jan; 72(1):107-12. PubMed ID: 11210066 [TBL] [Abstract][Full Text] [Related]
4. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group. Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751 [TBL] [Abstract][Full Text] [Related]
5. [Acquired ichthyosis and haematological malignancies: five cases]. Berrady R; Baybay H; Khammar Z; Lahlou M; Lamchachti L; Gallouj S; El Hatimi A; Mernissi FZ; Bono W Ann Dermatol Venereol; 2012 Jan; 139(1):9-14. PubMed ID: 22225737 [TBL] [Abstract][Full Text] [Related]
6. [Limphomatous meningitis as recurrence site in Hodgkin's disease]. Greco M; Valsecchi M; Niccodemi C; Presas J; Corrado C; Winkel M Medicina (B Aires); 2006; 66(4):332-4. PubMed ID: 16977969 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for Hodgkin's disease. Ekert H N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536 [No Abstract] [Full Text] [Related]
8. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131 [TBL] [Abstract][Full Text] [Related]
9. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
10. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. Diehl V; Franklin J; Pfreundschuh M; Lathan B; Paulus U; Hasenclever D; Tesch H; Herrmann R; Dörken B; Müller-Hermelink HK; Dühmke E; Loeffler M; N Engl J Med; 2003 Jun; 348(24):2386-95. PubMed ID: 12802024 [TBL] [Abstract][Full Text] [Related]
11. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease. Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744 [TBL] [Abstract][Full Text] [Related]
12. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]. Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905 [TBL] [Abstract][Full Text] [Related]
13. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V; J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100 [TBL] [Abstract][Full Text] [Related]
14. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068 [TBL] [Abstract][Full Text] [Related]
15. [Primary treatment of advanced Hodgkin's disease]. Illés A; Udvardy M; Molnár Z Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586 [TBL] [Abstract][Full Text] [Related]
16. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group. Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP; Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253 [TBL] [Abstract][Full Text] [Related]
17. Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. Janjetovic S; Janning M; Daukeva L; Bokemeyer C; Fiedler W Tumori; 2013; 99(3):e96-9. PubMed ID: 24158090 [TBL] [Abstract][Full Text] [Related]
18. [Hodgkin's disease and infection with human immunodeficiency virus]. Auguet Quintillá T; Pedro-Botet Montoya J; Planas Domingo J; Gallén Castillo M Sangre (Barc); 1992 Feb; 37(1):39-41. PubMed ID: 1374934 [TBL] [Abstract][Full Text] [Related]
19. [Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]. Baron F; Hermanne JP; Fassotte MF; Beguin Y; Fillet G Rev Med Liege; 1998 Nov; 53(11):651-3. PubMed ID: 9887654 [TBL] [Abstract][Full Text] [Related]
20. [Controversy regarding the treatment of Hodgkin's disease]. Balwierz W; Armata J Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966 [No Abstract] [Full Text] [Related] [Next] [New Search]